Macrogenics (MGNX) Gross Profit (2020 - 2026)

Macrogenics (MGNX) has reported Gross Profit for 6 consecutive years, with $41.2 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Gross Profit rose 3.67% year-over-year to $41.2 million; the TTM figure through Dec 2025 stood at $149.5 million (down 11.94% YoY), while the FY2025 annual figure was $149.5 million, changed 0.26% from the prior year.
• Gross Profit fell to $41.2 million in Q4 2025 per MGNX's latest filing, from $72.8 million in the prior quarter.
• Across five years, Gross Profit topped out at $110.5 million in Q3 2024 and bottomed at $8.8 million in Q1 2024.
• Historically, Gross Profit has averaged $30.0 million across 5 years, with a median of $19.6 million in 2021.
• Annual changes were most pronounced in 2023 — Gross Profit sank 85.53% — and 2024, when it soared 971.96%.
• Macrogenics' Gross Profit stood at $13.2 million in 2021, then soared by 452.9% to $73.0 million in 2022, then tumbled by 85.53% to $10.6 million in 2023, then jumped by 276.69% to $39.8 million in 2024, then grew by 3.67% to $41.2 million in 2025.
• Business Quant data shows MGNX's Gross Profit at $41.2 million in Q4 2025, $72.8 million in Q3 2025, and $22.2 million in Q2 2025.